Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease
BelgiumA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
BelgiumA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
BelgiumStudy of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity
BelgiumA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
BelgiumStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
BelgiumA study to evaluate the safety of VTx-002 in patients with amyotrophic lateral sclerosis.
BelgiumComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
BelgiumA study of rilvegostomig and ramucirumab in patients with advanced or metastatic non-small cell lung cancer
BelgiumA study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.
BelgiumComparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
BelgiumA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
